Hana Biosciences
About:
Hana Biosciences is a biopharmaceutical company developing and commercializing differentiated cancer therapies.
Website: http://www.hanabiosciences.com
Top Investors: Warburg Pincus, Deerfield Capital Management
Description:
Hana Biosciences, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. The company's lead product candidate, Marqibo(R), potentially treats acute lymphoblastic leukemia and lymphomas.
Total Funding Amount:
$116M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2002-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2010-06-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai